Martinsville, NJ, United States of America

Patricia A Rhymer


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Patricia A Rhymer: Innovator in Cardiovascular Therapy

Introduction

Patricia A Rhymer is a notable inventor based in Martinsville, NJ (US). She has made significant contributions to the field of cardiovascular therapy, holding a total of 3 patents. Her work focuses on innovative solutions aimed at reducing the risks associated with cardiovascular diseases.

Latest Patents

Among her latest patents is a groundbreaking combination therapy designed to reduce the risks associated with cardiovascular disease. This invention involves pharmaceutical compositions that include a therapeutically effective amount of a cholesterol-reducing agent, such as an HMG-CoA reductase inhibitor, combined with a platelet aggregation inhibitor. This combination is useful for inhibiting platelet aggregation, preventing the formation of thrombotic occlusions, and treating, preventing, and reducing the risk of cardiovascular and cerebrovascular events, as well as related vaso-occlusive disorders.

Career Highlights

Patricia A Rhymer is currently associated with Merck & Co., Inc., where she continues to advance her research and development efforts in the pharmaceutical industry. Her innovative approaches have positioned her as a key player in the field of cardiovascular health.

Collaborations

Throughout her career, Patricia has collaborated with esteemed colleagues, including Robert J Gould and Steven A Nichtberger. These partnerships have further enhanced her research and contributed to the success of her inventions.

Conclusion

Patricia A Rhymer's contributions to cardiovascular therapy exemplify her dedication to innovation and improving health outcomes. Her patents reflect her commitment to advancing medical science and providing effective solutions for cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…